Volpara Health Technologies Ret. on assets
What is the Ret. on assets of Volpara Health Technologies?
The Ret. on assets of Volpara Health Technologies Limited is -11.20%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on ASX compared to Volpara Health Technologies
What does Volpara Health Technologies do?
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Companies with ret. on assets similar to Volpara Health Technologies
- Eden Research plc has Ret. on assets of -11.23%
- Barnwell Industries has Ret. on assets of -11.23%
- Giga Metals has Ret. on assets of -11.21%
- GIGA Metals has Ret. on assets of -11.21%
- China Eastern Airlines has Ret. on assets of -11.20%
- China Environmental Resources has Ret. on assets of -11.20%
- Volpara Health Technologies has Ret. on assets of -11.20%
- True North Gems has Ret. on assets of -11.19%
- International Travel House has Ret. on assets of -11.19%
- Million Stars has Ret. on assets of -11.19%
- Harrow Health has Ret. on assets of -11.19%
- Aurex has Ret. on assets of -11.19%
- Abacus Mining & Exploration has Ret. on assets of -11.19%